लोड हो रहा है...
Cardioprotective interventions for cancer patients receiving anthracyclines
BACKGROUND: Anthracyclines are among the most effective chemotherapeutic agents in the treatment of numerous malignancies. Unfortunately, their use is limited by a dose‐dependent cardiotoxicity. In an effort to prevent this cardiotoxicity, different cardioprotective agents have been studied. OBJECTI...
में बचाया:
| में प्रकाशित: | Cochrane Database Syst Rev |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley & Sons, Ltd
2011
|
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457676/ https://ncbi.nlm.nih.gov/pubmed/21678342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003917.pub4 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|